June 10 Who should be taking weight-loss drugs? Doctors share best candidates GLP-1 medications offer promising benefits for obesity and diabetes patients, with studies showing reduced heart attack risk and potential applications for addiction treatment.
May 28 Hoda Kotb reveals daughter's concerning diagnosis influenced her exit from 'Today' Hoda Kotb discusses leaving "The Today Show" to focus on her daughter Hope's type 1 diabetes, emphasizing the importance of spending time with family and managing her child's health.
May 23 Doctors warn of 'trifecta' of chronic illnesses plaguing Americans after MAHA report Chronic diseases such as obesity, diabetes and hypertension affect 133 million Americans, with the MAHA Commission urging action on better nutrition and diet.
May 17 Weight loss, diabetes drugs can cause mood changes: What to know about behavioral side effects Research on weight loss drugs like Ozempic shows varied results for mental health impacts, with some patients experiencing mood and personality changes.
May 3 Semaglutide found to have shocking benefit for liver disease patients in new study Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of patients and offering new hope for those with the life-threatening condition.
April 17 First GLP-1 pill for weight loss, diabetes shows success in late-phase trial Eli Lilly has seen positive results from a phase 3 trial of Orforglipron, the first-ever GLP-1 pill for weight loss and type 2 diabetes. Previous versions were administered via injection.
April 16 Diabetes risk linked to these ultraprocessed food combinations A new study found that certain combinations of food additives are linked to a higher chance of developing type 2 diabetes. Experts discuss how to mitigate risk.
April 12 Diabetes and weight-loss drug ‘changed my life,’ says senator: ‘I feel a decade younger’ Sen. John Fetterman, D-Pa., said Mounjaro changed his life with 'significant' health benefits. He's calling for widespread access to GLP-1 medications as doctors shared thoughts.
April 8 Diabetes 'rewires' the brain in surprising way, study finds In a new study, researchers found that type 2 diabetes can “rewire" the brain in ways similar to early Alzheimer’s disease. Experts comment on the link between high blood sugar and cognitive decline.
April 3 Ozempic, other semaglutides linked to hair loss: Here's what to know Popular medications for obesity and diabetes have been linked to an increased risk of hair loss, particularly for women. Researchers and doctors weigh in.